L Meijer Selected Research

L Meijer Research Topics

Disease

6	Neoplasms (Cancer) 12/2014 - 04/2000
5	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2000
2	Neuroblastoma 12/2014 - 10/2008
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2006 - 06/2001
2	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2000 - 01/2000
1	Neurobehavioral Manifestations 01/2022
1	Cystic Fibrosis (Mucoviscidosis) 11/2014
1	Cryptorchidism (Undescended Testes) 03/2012
1	Testicular Neoplasms (Testicular Cancer) 03/2012
1	Hypospadias 03/2012
1	Breast Neoplasms (Breast Cancer) 07/2010
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 10/2008
1	Chronic Kidney Failure (Chronic Renal Failure) 03/2008
1	Kidney Diseases (Kidney Disease) 03/2008
1	Infections 12/2001
1	Acquired Immunodeficiency Syndrome (AIDS) 08/2001
1	Necrosis 06/2001
1	Aneuploidy (Aneuploid) 06/2001
1	Polyploidy 06/2001
1	Malaria 05/2001
1	Endotoxin Hyporesponsiveness 04/2001
1	Alopecia (Baldness) 04/2001
1	Leukemia 01/2001
1	Chronic Disease (Chronic Diseases) 01/2001
1	Carcinoma (Carcinomatosis) 01/2001
1	Parkinson Disease (Parkinson's Disease) 01/2000
1	Pheochromocytoma 01/2000

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2000
4	indirubinIBA 10/2006 - 04/2000
3	Cyclin-Dependent Kinases (cdk Proteins)IBA 12/2014 - 06/2000
3	Phosphotransferases (Kinase)IBA 12/2014 - 01/2000
3	indirubin-3'-monoximeIBA 06/2001 - 01/2001
3	Carrier Proteins (Binding Protein)IBA 01/2001 - 01/2000
2	RoscovitineIBA 12/2014 - 10/2008
2	Pharmaceutical PreparationsIBA 03/2008 - 04/2000
2	indoleIBA 06/2001 - 01/2001
2	Protein Kinases (Protein Kinase)IBA 05/2001 - 01/2001
2	Glycogen Synthase Kinase 3IBA 01/2001 - 01/2000
1	Protein Kinase InhibitorsIBA 01/2022
1	((5Z)5- (1,3- benzodioxol- 5- yl)methylene- 2- phenylamino- 3,5- dihydro- 4H- imidazol- 4- one)IBA 01/2022
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 11/2014
1	Caspase 3 (Caspase-3)IBA 01/2014
1	InterferonsIBA 01/2014
1	Endocrine DisruptorsIBA 03/2012
1	Small Interfering RNA (siRNA)IBA 07/2010
1	Cyclin EIBA 07/2010
1	Trastuzumab (Herceptin)FDA Link 07/2010
1	purineIBA 10/2008
1	CarbazolesIBA 03/2005
1	Antiparasitic Agents (Antiparasitics)IBA 12/2001
1	Antimitotic AgentsIBA 12/2001
1	pancratistatinIBA 12/2001
1	7-deoxynarciclasineIBA 12/2001
1	Antiviral Agents (Antivirals)IBA 08/2001
1	NIMA-Related KinasesIBA 05/2001
1	Toll-Like Receptor 4IBA 04/2001
1	CyclinsIBA 04/2001
1	Glycogen Synthase (Synthase I)IBA 01/2001
1	ElementsIBA 12/2000
1	LipidsIBA 12/2000
1	Cyclin D1IBA 12/2000
1	GlycogenIBA 12/2000
1	beta CateninIBA 12/2000
1	Insulin (Novolin)FDA Link 12/2000
1	alsterpaulloneIBA 10/2000
1	EnzymesIBA 10/2000
1	Glycogen Synthase Kinase 3 betaIBA 10/2000
1	StaurosporineIBA 04/2000
1	alvocidib (flavopiridol)IBA 04/2000
1	alpha-SynucleinIBA 01/2000
1	hymenialdisineIBA 01/2000
1	Biological ProductsIBA 01/2000
1	AntibodiesIBA 01/2000

Therapy/Procedure

2	Chinese Traditional Medicine (Traditional Chinese Medicine) 06/2001 - 01/2001
1	Drug Therapy (Chemotherapy) 04/2001
1	Therapeutics 04/2001